DCK and cancer: Decreased dCK levels contribute to gemcitabine resistance by reducing the level of the active gemcitabine form.26 dCK also participates in DNA damage and repair, a process that contributes for radiotherapy resistance.27 However, the impact of dCK on signal transduction in cancer cells has seldom been documented.